| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000031268 |
| Receipt No. | R000035603 |
| Official scientific title of the study | Development of a comprehensive treatment based on psychosocial approach for support for the individuals with early psychosis |
| Date of disclosure of the study information | 2018/02/20 |
| Last modified on | 2018/02/13 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Development of a comprehensive treatment based on psychosocial approach for support for the individuals with early psychosis | |
| Title of the study (Brief title) | Development of a comprehensive treatment based on psychosocial approach for support for the individuals with early psychosis | |
| Region |
|
|
| Condition | ||||
| Condition | Psychotic disorders
A nurse working in a Psychiatric hospital |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Focusing on individuals with early psychosis hospitalized in a psychiatric ward, we aim to: 1. provide a comprehensive assessment that covers aspects such as psychiatric symptoms and psychosocial functioning; 2. create a care plan that focuses on improving psychological adaptation and social function, 3. develop a psychoeducational and relapse prevention program for early psychosis that encompasses cognitive-behavioral approach; and 4. train more nurses in order to implement and adapt this approach to the present conditions in Japan.
To achieve this, we would like to create a program in Japan that draws upon programs being used in another developed nation, the United Kingdom. Additionally, we intend to conduct surveys of patients and families as well as qualitative research including citation of individual examples on how the treatment benefits patients individually. By understanding the effectiveness of treatment, interventional needs, and satisfaction levels, we hope to develop a higher-quality support program. We will also conduct a questionnaire survey regarding nurses'level of interest in this psychosocial approach, and their thoughts on its future feasibility. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Psychiatric symptoms: We will assess psychiatric symptoms using the Positive And Negative Syndrome Scale, Beck Cognitive Insight Scale, and Beck Depression Inventory.
Surveys: We will survey the level of insufficiency of and level of satisfaction with the service via self-evaluations regarding the outcome of the program, and assess the knowledge of and response to the treatment and the illness. These surveys will be conducted on both patients and their families separately. An additional survey will be conducted targeting on the nurses who would provide the service based on present program in the future. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Educational,Counseling,Training | ||
| Type of intervention |
|
||
| Interventions/Control_1 | 1. Comprehensive assessment: We aim to perform initial assessments in around 3 sessions.
2. Creation of the care plan: The care plan will be created after conducting the comprehensive assessments, and will be based on the information acquired from the psychiatrists and other staffs in charge of the patients. 3. Psychosocial intervention: The psychosocial intervention will be performed in accordance with the care plan, to support the patients' psychological issues and social functioning, and to provide psychoeducation, as required. 4. Performance of relapse drills: Relapse drills will be performed in accordance with the relapse-drill protocol. An additional survey will be conducted targeting on the nurses who would provide the service based on present program in the future. |
||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inclusion criteria: We will target approximately 20 individuals with psychotic disorders aged 14 to 36 years, who have had an onset of a psychotic disorder within the past five years. Diagnosis will be based on the Diagnostic and Statistical Manual of Mental Disorders-IV (American Psychiatric Association), and diagnoses may include brief psychotic disorder, schizophreniform disorder, schizophrenia, delusional disorder, schizoaffective disorder, and mood disorders with psychotic features. | |||
| Key exclusion criteria | Cases with neurological disorders or substance dependence will be excluded. | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Norika Mitsunaga |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | 2-1,Seiryo-machi, Aoba-Ku, Sendai, 980-8575, Japan |
| Address | +81-22-717-7916 |
| TEL | 022-717-7916 |
| mitsuanga@med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Norika Mitsunaga |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | 2-1,Seiryo-machi, Aoba-Ku, Sendai, 980-8575, Japan |
| Address | +81-22-717-7916 |
| TEL | 022-717-7916 |
| Homepage URL | |
| mitsuanga@med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tohoku University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035603 |